Clinical trials
Terminated Phase 2 Lung Diseases, Interstitial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Diffusion Pharmaceuticals Inc | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Evans Fernandez Perez | 1 |
| Furiex Pharmaceuticals, Inc | 1 |
| Maisonneuve-Rosemont Hospital | 1 |
| Matthias Griese | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Michael M. Pham | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 13 |
| Pulmonary Fibrosis | 5 |
| Fibrosis | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Scleroderma, Systemic | 3 |
| Respiratory Tract Diseases | 2 |
| Respiratory Tract Infections | 2 |
| Bacterial Infections | 1 |
| Bronchiolitis Obliterans | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.